Related Experiment Videos
Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides
C Chavany1, T Le Doan, P Couvreur
1Laboratoire de Biophysique, Muséum National d'Histoire Naturelle, INSERM U 201, CNRS URA 481, Paris, France.
Pharmaceutical Research
|April 1, 1992
Summary
Hydrophobic cations facilitate oligonucleotide adsorption onto nanoparticles, forming ion pairs. These nanoparticles offer protection and delivery for oligonucleotides, showing promise for cellular applications.
Area of Science:
- Polymer Science
- Nucleic Acid Chemistry
- Nanotechnology
Background:
- Oligonucleotides require carriers for effective cellular delivery.
- Nanoparticles offer potential as protective and delivery vehicles for biomolecules.
Purpose of the Study:
- To investigate the adsorption of oligothymidylates onto cyanoacrylate nanoparticles.
- To explore the role of hydrophobic cations in oligonucleotide-nanoparticle complexation.
- To assess the protective capabilities of these nanoparticles against enzymatic degradation.
Main Methods:
- Adsorption studies using oligothymidylates and polyisobutyl/polyisohexylcyanoacrylate nanoparticles.
- Utilized hydrophobic cations (tetraphenylphosphonium chloride, quaternary ammonium salts) for ion-pair formation.
- Determined carrier capacity and evaluated in vitro protection against snake venom phosphodiesterase.
Main Results:
- Oligonucleotide adsorption is mediated by ion pair formation between phosphate groups and hydrophobic cations.
- Adsorption efficiency depends on oligonucleotide length, nanoparticle type, cation hydrophobicity, and ionic concentration.
- Polyisohexylcyanoacrylate nanoparticles demonstrated a carrier capacity of 5 μmol/g for 16-nucleotide oligothymidylates with cetyltrimethylammonium bromide.
- Adsorbed oligothymidylates showed protection against 3'-exonuclease degradation.
Conclusions:
- Cyanoacrylate nanoparticles effectively carry and protect oligothymidylates via hydrophobic cation complexation.
- These nanoparticles represent a viable system for oligonucleotide delivery in cellular contexts.
- Potential for future in vivo applications in oligonucleotide-based therapies.